Navigation Links
Life Sciences Industry Reaches Crossroad Say Noted Pillsbury Attorneys
Date:3/17/2008

sbury's Health Care practice and founder of the Healthcare Technology Network of Greater Washington. Main advocates healthcare clients' interests on Capitol Hill and before regulatory bodies, including the Centers for Medicare and Medicaid Services (CMS) and state health and insurance departments.

Main and Wetherell agree that among the most crucial factors affecting life sciences are:

-- Growth in the pharmaceutical market is expected to be between five and

six percent this year, reaching record sales of $740 billion, according

to the IMS Health's 2008 Global Pharmaceutical Market and Therapy

Forecast.

-- While Big Pharma is reaping huge rewards distributing blockbuster

pills, most new drugs are developed at small, innovative start-ups,

while R&D costs are rising -- to the tune of $55 billion in 2006 alone.

Accordingly, the number of strategic alliances, licensing deals, and

mergers has increased as companies seek new products on shorter

timetables.

-- Developing the right products is critical for firms requiring approval

from the U.S. Patent and Trademark Office and Food and Drug

Administration. Backlogs in applications make it hard for companies to

recoup investments at a time when novel drugs, diagnostic equipment,

implantable devices and other goods generally must yield sales in the

hundreds of millions to cover research costs. A lengthened approval

process is especially difficult for small companies with limited

funding, who often cannot sustain years of procedural delays.

-- Regulators, including the Federal Trade Commission and the Department

of Justice, are shining light on the industry. Among other

investigations, the FTC is exploring the competitive implications of

deals in which brand-name pharmaceutical companies allegedly

collaborated with thei
'/>"/>

SOURCE Pillsbury Winthrop Shaw Pittman LLP
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
5. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
6. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
7. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
8. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
9. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
10. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
11. The Pittsburgh Life Sciences Greenhouse Adds New Companies to its Investment Portfolio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... La Jolla, CA (PRWEB) July 23, 2014 ... adipose stem cell therapy in the US aimed at ... today announced their newest clinical study for Parkinson’s disease. ... and efficacy of stem cell therapy are paramount when ... , This clinical study makes stem cell therapy accessible ...
(Date:7/23/2014)... July 23, 2014 ... of Trendlines Agtech , announced it has ... Israel,s leading agricultural thermoplastics applications companies. ... Valentis,s technology combines nanocrystalline cellulose (NCC), a biodegradable, ... additional nanoparticles to produce highly improved polymeric films. ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 DuPont Pioneer ... business as vice president of Agricultural Biotechnology (ABT), effective ... where he served most recently as president, chief executive ... and business leadership in the seed and crop protection ... Paul E. Schickler , president of DuPont Pioneer. ...
(Date:7/23/2014)... , July 23, 2014 /PRNewswire/ - BioAmber ... biotechnology company producing sustainable chemicals, today announced that the ... full their option to purchase an additional 420,000 ... price of $12.00 per share, less underwriting discounts ... underwritten public offering of 2,800,000 shares of common ...
Breaking Biology Technology:StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 3BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 3
... 4, 2008, SAN DIEGO, Oct. 27 Neurocrine ... Gorman, President and Chief,Executive Officer of Neurocrine Biosciences will ... New York., The live presentation takes place Tuesday, ... a.m. Pacific Time (PT). The presentation will,be simultaneously webcast ...
... BioTrends Research Group, Inc. was,named one of ... Philadelphia region by the Philadelphia 100(R), a joint ... Entrepreneurs, Forum of,Greater Philadelphia, and the Philadelphia Business ... "This recognition is a testament to the ...
... Osteotech, Inc.,(Nasdaq: OSTE ) announced today ... financial results will be released Friday, November 7,2008. ... Owusu-Akyaw, President and,Chief Executive Officer, as well as ... 2008, at 9:00 a.m. Eastern time. You are ...
Cached Biology Technology:Neurocrine Biosciences to Present at the Oppenheimer 19th Annual Healthcare Conference 2
(Date:7/22/2014)... spot with natural tourism resources, a recent study revealed a ... Geoscience and Mineral Resources (KIGAM) indicated that there are the ... 5,000 years ago. That is the first time to actually ... volcano 5,000 years ago in the inland part of the ... The research team led by Dr. Jin-Young Lee confirmed in ...
(Date:7/22/2014)... The darker side of meerkats which sees them prevent ... explained in a new study. , Research into the desert ... pair and many adult helpers shows that the alpha ... breed. , The study shows how this way of life, ... can prove effective despite its sinister side. , Dominant ...
(Date:7/22/2014)... July 22, 2014, Cleveland: A type of immune ... diseases, such as Alzheimer,s disease and multiple sclerosis ... brain injury (TBI) and may slow the progression ... published today in the online journal Nature ... Bruce Trapp, PhD, Chair of the Department of ...
Breaking Biology News(10 mins):Jeju Island is a live volcano 2Cleveland Clinic researchers discover neuroprotective role of immune cell 2
... of North Africa,s major droughts of centuries past, reveals ... year 1179. The first multi-century drought reconstruction that ... droughts during the 13th and 16th centuries and the ... international research team figured out northwest Africa,s climate history ...
... University of Rochester Medical Center scientists discovered a defect ... earliest stages of abnormal skull development in newborns, known as ... pathways set off a cascade of events that regulate bone ... published May 25, 2010, in the journal Science Signaling ...
... Association today launched a first-of-its-kind educational tool to ... college and university professors provide evidence to support ... academic world is commonly predicated on judging a ... Sally T. Hillsman, ASA,s Executive Officer. "While teaching ...
Cached Biology News:20th century one of driest in 9 centuries for northwest Africa 220th century one of driest in 9 centuries for northwest Africa 3Stem-cell disruption induces skull deformity, UR study shows 2American Sociological Association launches first-of-its-kind teaching tool 2American Sociological Association launches first-of-its-kind teaching tool 3
BD BioCoat Matrigel Matrix 35 mm Culture Dishes Coating : BD MatrigelTM Basement Membrane Matrix ,Surface : ECM/attachment factors ,Surface area : 9.6 cm2 ,Dim nominal : 35 mm x 10 mm ,Vo...
BD BioCoat Fibronectin 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of human fibronectin....
... Mouse Antibody to Human Cytokeratin TYPE ... Basic (Type II) keratins. Including epidermal cell ... at 58kD, 65kD and 67kD. Broad keratin ... oesophagus and cornea. Immunogen: ...
BD BioCoat Fibronectin 150 mm Culture Dishes...
Biology Products: